SCHECHTER JONATHAN — SEC Form 4 filings
SEC reporting owner CIK 1619259. 12 Form 4 filings on record with FilingPulse; latest filed 2026-07-17.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-04-10 to 2026-07-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 4 filings — 85,000 shares, $108,128 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: purchase of 10,000 shares @ $2.73 ($27,321) in Oblong, Inc., filed 2025-09-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Oblong, Inc. (OBLG) | Director | 3 | 3 legs · 25,000 sh · $59,896 | — | — |
| PharmaCyte Biotech, Inc. (PMCB) | Director | 5 | 3 legs · 60,000 sh · $48,232 | — | 6 |
| TAO Synergies Inc. (TAOX) | Director | 4 | — | — | 5 |
Form 4 filings — SCHECHTER JONATHAN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-17 | 4/A | PharmaCyte Biotech, Inc. (PMCB) | Other (J): 0 (derivative) | EDGAR |
| 2026-04-02 | 4 | PharmaCyte Biotech, Inc. (PMCB) | Grant/award (A): 119,170 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | PharmaCyte Biotech, Inc. (PMCB) | Purchase (P): 20,000 @ $0.78 · Purchase (P): 20,000 @ $0.79 · Purchase (P): 20,000 @ $0.84 | EDGAR |
| 2025-12-12 | 4 | PharmaCyte Biotech, Inc. (PMCB) | Grant/award (A): 150,000 @ $0 · Tax withholding (F): 67,500 @ $1.02 · Grant/award (A): 63,233 (derivative) @ $0 | EDGAR |
| 2025-11-17 | 4 | Oblong, Inc. (OBLG) | Purchase (P): 10,000 @ $1.91 | EDGAR |
| 2025-10-17 | 4 | TAO Synergies Inc. (TAOX) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-09-17 | 4 | Oblong, Inc. (OBLG) | Purchase (P): 5,000 @ $2.70 | EDGAR |
| 2025-09-16 | 4 | Oblong, Inc. (OBLG) | Purchase (P): 10,000 @ $2.73 | EDGAR |
| 2025-07-02 | 4 | TAO Synergies Inc. (TAOX) | Grant/award (A): 21,575 @ $0 · Tax withholding (F): 8,630 @ $7.85 | EDGAR |
| 2025-04-07 | 4 | Synaptogenix, Inc. (SNPX) | Grant/award (A): 800 (derivative) @ $0 | EDGAR |
| 2024-07-17 | 4 | PharmaCyte Biotech, Inc. (PMCB) | Grant/award (A): 38,009 (derivative) @ $0 | EDGAR |
| 2024-04-10 | 4 | Synaptogenix, Inc. (SNPX) | Grant/award (A): 800 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1619259 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →